Venetoclax (Venclexta®) on PBS from December 1, 2021
2021-11-29
Vital cancer treatment is now available through Pharmaceutical Benefits Scheme (PBS) for more Australians living with blood cancer The Leukaemia Foundation welcomes the Federal Government’s announcement that the targeted cancer treatment Venetoclax (Venclexta®), will be added to Pharmaceutical Benefits Scheme (PBS) from 1 December 2021 for Australians living with acute myeloid leukaemiaRead More →